Reply S.p.A. (REJA.F)
| Previous close | 125.90 |
| Open | 126.40 |
| Bid | 126.30 x 0 |
| Ask | 128.10 x 0 |
| Day's range | 126.40 - 126.40 |
| 52-week range | 82.50 - 133.40 |
| Volume | |
| Avg. volume | 36 |
| Market cap | 4.753B |
| Beta (5Y monthly) | 1.01 |
| PE ratio (TTM) | 25.23 |
| EPS (TTM) | 5.01 |
| Earnings date | 14 May 2024 |
| Forward dividend & yield | 1.00 (0.79%) |
| Ex-dividend date | 20 May 2024 |
| 1y target est | N/A |
Business WireThe Reply AI Film Festival 2024 is Underway.
TURIN, Italy, May 09, 2024--Reply presents the inaugural Reply AI Film Festival, an international competition where Artificial Intelligence (AI) serves not only as a catalyst for innovation in the realm of creative storytelling but also as a tool for fostering inclusivity among younger generations in video and film production.
Business WireREPLY S.p.A.: Shareholders’ Meeting Approves the 2023 Financial Statements
TURIN, Italy, April 23, 2024--The General Shareholders’ meeting of Reply S.p.A. [EXM, STAR: REY] today approved the Financial Statements for the financial year 2023, confirming the distribution of a gross dividend of €1.00 per share.
Business WireREPLY: Value Based Medicine Is Born, the Platform Created by Laife Reply for IEO That Makes Patient Care Increasingly Personalised and Appropriate
TURIN, Italy, April 22, 2024--Laife Reply, a company within the Reply Group focused on using AI, Big Data and Machine Learning to innovate preventive healthcare and treatment processes has developed, in collaboration with IEO (European Institute of Oncology), the Value Based Medicine (VBM), a web platform to support the patient care cycle.
